BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25070665)

  • 1. 18F-fluorodeoxyglucose positron emission tomography/computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus.
    Hara T; Truelove J; Tawakol A; Wojtkiewicz GR; Hucker WJ; MacNabb MH; Brownell AL; Jokivarsi K; Kessinger CW; Jaff MR; Henke PK; Weissleder R; Jaffer FA
    Circulation; 2014 Sep; 130(13):1044-52. PubMed ID: 25070665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging Predicts Vein Wall Scarring and Statin Benefit in Murine Venous Thrombosis.
    Kessinger CW; Qi G; Hassan MZO; Henke PK; Tawakol A; Jaffer FA
    Circ Cardiovasc Imaging; 2021 Mar; 14(3):e011898. PubMed ID: 33724049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to Letter Regarding Article, "18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Enables the Detection of Recurrent Same-Site Deep Vein Thrombosis by Illuminating Recently Formed, Neutrophil-Rich Thrombus".
    Tawakol A; Hara T; Truelove J; Wojtkiewicz GR; Hucker WJ; MacNabb MH; Brownell AL; Jokivarsi K; Kessinger CW; Jaff MR; Henke PK; Weissleder R; Jaffer FA
    Circulation; 2015 Jun; 131(24):e531-2. PubMed ID: 26078375
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter by Klok et al Regarding Article, "18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Enables the Detection of Recurrent Same-Site Deep Vein Thrombosis by Illuminating Recently Formed, Neutrophil-Rich Thrombus".
    Klok FA; Tan M; Huisman MV
    Circulation; 2015 Jun; 131(24):e530. PubMed ID: 26078374
    [No Abstract]   [Full Text] [Related]  

  • 5. (18)F-FDG PET in the evaluation of acuity of deep vein thrombosis.
    Rondina MT; Lam UT; Pendleton RC; Kraiss LW; Wanner N; Zimmerman GA; Hoffman JM; Hanrahan C; Boucher K; Christian PE; Butterfield RI; Morton KA
    Clin Nucl Med; 2012 Dec; 37(12):1139-45. PubMed ID: 23154470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma.
    Sun L; Guan YS; Pan WM; Chen GB; Luo ZM; Wei JH; Wu H
    World J Gastroenterol; 2008 Feb; 14(8):1212-7. PubMed ID: 18300346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation modulates murine venous thrombosis resolution in vivo: assessment by multimodal fluorescence molecular imaging.
    Ripplinger CM; Kessinger CW; Li C; Kim JW; McCarthy JR; Weissleder R; Henke PK; Lin CP; Jaffer FA
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2616-24. PubMed ID: 22995524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of 18F fluoro-2-désoxy-D-glucose positron emission tomography/computed tomography for the diagnosis of venous thromboembolism.
    Le Roux PY; Robin P; Delluc A; Tardy B; Abgral R; Couturaud F; Reffad A; Le Gal G; Salaun PY
    Thromb Res; 2015 Jan; 135(1):31-5. PubMed ID: 25455997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of FDG PET/CT imaging for venous thromboembolic disorders: preliminary results from a prospective, observational pilot study.
    Hess S; Madsen PH; Iversen ED; Frifelt JJ; Høilund-Carlsen PF; Alavi A
    Clin Nucl Med; 2015 Jan; 40(1):e23-6. PubMed ID: 24999680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of 18 F-FDG PET/CT in the diagnosis of benign vs. malignant tumor thrombus.
    Sarswat S; Khan D; Sagar S; Kumar R
    Nucl Med Commun; 2023 Aug; 44(8):726-731. PubMed ID: 37272295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis.
    Hu S; Zhang J; Cheng C; Liu Q; Sun G; Zuo C
    Abdom Imaging; 2014 Dec; 39(6):1221-7. PubMed ID: 24913670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence.
    Hara T; Bhayana B; Thompson B; Kessinger CW; Khatri A; McCarthy JR; Weissleder R; Lin CP; Tearney GJ; Jaffer FA
    JACC Cardiovasc Imaging; 2012 Jun; 5(6):607-15. PubMed ID: 22698530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET-CT in the diagnosis of tumor thrombus: can it be differentiated from benign thrombus?
    Sharma P; Kumar R; Jeph S; Karunanithi S; Naswa N; Gupta A; Malhotra A
    Nucl Med Commun; 2011 Sep; 32(9):782-8. PubMed ID: 21799368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
    Li DL; Xu YK; Wang QS; Wu HB; Li HS
    Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
    Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can (18)F-FDG PET/CT scan change treatment planning and be prognostic in recurrent colorectal carcinoma? A prospective and follow-up study.
    Artiko V; Odalovic S; Sobic-Saranovic D; Petrovic M; Stojiljkovic M; Petrovic N; Kozarevic N; Grozdic-Milojevic I; Obradovic V
    Hell J Nucl Med; 2015; 18(1):35-41. PubMed ID: 25840571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in the detection of locoregional recurrence in head and neck malignancies: F-18 fluorodeoxyglucose-positron emission tomography/computed tomography compared to high-resolution contrast-enhanced computed tomography and endoscopic examination.
    Rangaswamy B; Fardanesh MR; Genden EM; Park EE; Fatterpekar G; Patel Z; Kim J; Som PM; Kostakoglu L
    Laryngoscope; 2013 Nov; 123(11):2664-9. PubMed ID: 23553147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.